Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01128829 · ClinicalTrials.gov registry record · NA
Sugar-replacement Sweeteners, and Blood Sugar Control
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT01128829 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 17 participants.
The verdict
NCT01128829, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
Several sugar-replacement sweeteners are currently on the market, including saccharine (ex. Sweet'N Low), aspartame (ex. Equal), and sucralose (ex. Splenda). The purpose of this study is to examine wether non caloric sweeteners affects how well the body works to control blood sugar. The study includes detailed blood sugar testing after drinking liquids that may contain sucralose. The investigators hypothesize that drinking liquids with sucralose will effect the amounts of specific appetite-affecting substances naturally produced by the body.
Interventions
- OTHER Water
- OTHER Sucralose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2010-05 |
| Est. Completion | 2012-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01128829
The ClinicalTrials.gov registry entry for NCT01128829 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Water is the first listed.
NCT01128829 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01128829 about?
NCT01128829 is a clinical study titled "Sugar-replacement Sweeteners, and Blood Sugar Control". Several sugar-replacement sweeteners are currently on the market, including saccharine (ex. Sweet'N Low), aspartame (ex. Equal), and sucralose (ex. Splenda). The purpose of this study is to examine wether non caloric sweeteners affects how well the body works to control blood sugar. The study includ...
What is the current status of trial NCT01128829?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2010-05. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01128829?
The interventions under investigation include: Water (OTHER), Sucralose (OTHER).
Who is sponsoring clinical trial NCT01128829?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.